independence blue cross glp 1 restricts health coverage for weight loss drugs Excellus BCBS will stop paying
Description
A once-daily oral small-molecule GLP-1 receptor agonist delivered progressive, dose-dependent weight loss without food or fluid restrictions, supporting larger phase 3 trials for long-term weight management
References 1 ShahPKalraSYadavYDekaNLathiaTJacobJJet al
Additionally, the peripheral administration of exendin-4 and liraglutide regulates food intake by activating the GLP-1 receptors expressed on both vagal afferents and CNS [139]
It does not simply reverse on its own.
I want to take the medication
